Bendamustine/Rituximab Followed by Venetoclax and Rituximab for Treatment of Chronic Lymphocytic Leukemia
Columbia University
Columbia University
University of Arizona
German CLL Study Group
German CLL Study Group
Cedars-Sinai Medical Center
St. Petersburg State Pavlov Medical University
University of Giessen
AbbVie
M.D. Anderson Cancer Center
St. Petersburg State Pavlov Medical University
Wake Forest University Health Sciences
Hoffmann-La Roche
University of Wisconsin, Madison
Brown University
Arbeitsgemeinschaft medikamentoese Tumortherapie
Aptevo Therapeutics
Gilead Sciences
St. Petersburg State Pavlov Medical University
Genentech, Inc.
Gruppo Italiano Malattie EMatologiche dell'Adulto
German CLL Study Group
M.D. Anderson Cancer Center
Gilead Sciences
Janssen Research & Development, LLC
Genentech, Inc.
Hoffmann-La Roche
University of Wisconsin, Madison
TG Therapeutics, Inc.
Hoffmann-La Roche
Alliance for Clinical Trials in Oncology
German CLL Study Group
University of California, Davis
German CLL Study Group
Dartmouth-Hitchcock Medical Center
Massachusetts General Hospital
Lundbeck Canada Inc.
Aptevo Therapeutics
MedImmune LLC
University of Washington
Novartis
SCRI Development Innovations, LLC
Teva Branded Pharmaceutical Products R&D, Inc.
Hoffmann-La Roche
Georgetown University
Jiangsu Simcere Pharmaceutical Co., Ltd.
AbbVie